Gene · 4938
Papers3,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Precise identification of cell states altered in disease using healthy single-cell references. | Nat Genet | 2023 | 37828140 | PubTator, text mining | PubMed |
| OAS1 suppresses African swine fever virus replication by recruiting TRIM21 to degrade viral major capsid protein. | J Virol | 2023 | 37815352 | PubTator, text mining | PubMed |
| Occurrence of SARS-CoV-2 viremia is associated with genetic variants of genes related to COVID-19 pathogenesis. | Front Med (Lausanne) | 2023 | 37809329 | PubTator, text mining | PubMed |
| Identification of human genetic variants modulating the course of COVID-19 infection with importance in other viral infections. | Front Genet | 2023 | 37795240 | PubTator, text mining | PubMed |
| Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia. | Front Immunol | 2023 | 37795087 | PubTator, text mining | PubMed |
| Alternative splicing in lung influences COVID-19 severity and respiratory diseases. | Nat Commun | 2023 | 37794074 | PubTator, text mining | PubMed |
| Zika virus modulates mitochondrial dynamics, mitophagy, and mitochondria-derived vesicles to facilitate viral replication in trophoblast cells. | Front Immunol | 2023 | 37781396 | PubTator, text mining | PubMed |
| RNA-Seq and Immune Repertoire Analysis of Normal and Hepatocellular Carcinoma Relapse After Liver Transplantation. | Int J Gen Med | 2023 | 37781272 | PubTator, text mining | PubMed |
| Therapeutic Potential of Biochanin A in Herpes Simplex Keratitis. | Pharmaceuticals (Basel) | 2023 | 37765049 | PubTator, text mining | PubMed |
| Interferons-Implications in the Immune Response to Respiratory Viruses. | Microorganisms | 2023 | 37764023 | PubTator, text mining | PubMed |
| Exploring the Immune Response against RSV and SARS-CoV-2 Infection in Children. | Biology (Basel) | 2023 | 37759622 | PubTator, text mining | PubMed |
| Bioinformatics analysis to reveal the potential comorbidity mechanism in psoriasis and nonalcoholic steatohepatitis. | Skin Res Technol | 2023 | 37753698 | PubTator, text mining | PubMed |
| Type I/type III IFN and related factors regulate JEV infection and BBB endothelial integrity. | J Neuroinflammation | 2023 | 37752509 | PubTator, text mining | PubMed |
| The unique interplay of mitochondrial oxidative phosphorylation (OXPHOS) and immunity and its potential implication for the sex- and age-related morbidity of severe COVID-19 patients. | MedComm (2020) | 2023 | 37750090 | PubTator, text mining | PubMed |
| Downregulation of RCN1 promotes pyroptosis in acute myeloid leukemia cells. | Mol Oncol | 2023 | 37746742 | PubTator, text mining | PubMed |
| INHAT subunit SET/TAF-Iβ regulates PRC1-independent H2AK119 mono-ubiquitination via E3 ligase MIB1 in colon cancer. | NAR Cancer | 2023 | 37746636 | PubTator, text mining | PubMed |
| High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population. | Front Oncol | 2023 | 37746264 | PubTator, text mining | PubMed |
| Pan-cancer analysis identified OAS1 as a potential prognostic biomarker for multiple tumor types. | Front Oncol | 2023 | 37746262 | PubTator, text mining | PubMed |
| Association of IFNAR2 rs2236757 and OAS3 rs10735079 Polymorphisms with Susceptibility to COVID-19 Infection and Severity in Palestine. | Interdiscip Perspect Infect Dis | 2023 | 37745867 | PubTator, text mining | PubMed |
| Global impact of aberrant splicing on human gene expression levels. | bioRxiv | 2023 | 37745605 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4938/papers?page=19